Sargent Bickham Lagudis LLC Natera, Inc. Transaction History

Sargent Bickham Lagudis LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$86.26 - $119.0 $12,421 - $17,136	-144 Closed	0 $0
Q1 2021 May 24, 2021	BUY	$91.47 - $124.36 $7,683 - $10,446	84 Added 140.0%	144 $15,000
Q4 2020 May 24, 2021	SELL	$66.66 - $111.74 $5,599 - $9,386	-84 Reduced 58.33%	60 $6,000
Q4 2020 May 24, 2021	BUY	$66.66 - $111.74 $9,599 - $16,090	144 New	144 $15,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.